Portland Patient Receives Vivistim Implant for Stroke
A stroke survivor from La Center underwent a 90-minute procedure at Oregon Health & Science University to aid her recovery.
Updated on Oct. 20, 2026 in Stroke
On September 4, 47-year-old Lauren Vogel received a Vivistim device implant at Oregon Health & Science University to treat the lingering effects of a 2023 stroke. The patient, a resident of La Center, experienced left-side paralysis and is now awaiting the activation of the medical device.
Why it matters
The Vivistim system aims to stimulate the vagus nerve to reduce local brain inflammation and encourage the formation of new neural connections. This approach offers a new avenue for recovery for individuals dealing with chronic physical impairments following an ischemic stroke.
The Vivistim procedure involves a 90-minute surgery to place the device under the chest skin and connect it to the vagus nerve. The device, which was approved by the FDA in 2021, sends electrical signals to help brain cells regenerate.
The players
Lauren Vogel
She is a 47-year-old stroke survivor from La Center who received a neurostimulation implant to assist with her recovery.
Oregon Health & Science University
Located in Portland, this public research university and medical center is a leader in clinical care and biomedical research.
The details
The device operates by sending small electrical signals along the vagus nerve to support recovery. Lauren Vogel, who suffered from left-side paralysis after her 2023 stroke, is scheduled for the next phase of her treatment in November.
Timeline
Lauren Vogel suffered a stroke in 2023.
The FDA approved the Vivistim device in 2021.
Vogel received the Vivistim device implant on September 4, 2026.
Vogel's device is scheduled to be activated in November 2026.
Health Landscape
This procedure extends the clinical application of the FDA's 2021 approval of the Vivistim system. The integration of neurostimulation technology marks a shift in stroke rehabilitation, moving beyond traditional physical therapy to active nerve intervention.
Patients dealing with post-stroke paralysis may find this nerve-stimulation therapy provides a new option for brain cell regeneration. Those considering similar procedures should discuss the 90-minute surgical requirements and recovery timelines with their neurologists.
The takeaway
Advancements in neurostimulation are increasingly offering tangible hope for stroke survivors facing long-term physical limitations. Patients interested in such technology should consult with specialized medical centers to determine if their specific condition qualifies for the procedure.
What happens next
Lauren Vogel is scheduled to have her implanted Vivistim device activated in November 2026.
Further reading
For more information on current treatment options, visit the Stroke section.
Source note: This article includes information reported by The Columbian.
